指南与共识前列腺癌

临床局限性前列腺癌:AUA/ASTRO指南第二部分:主动监测原则、手术原则与随访

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up.
指南 / 共识 · J Urol · 2022-05-10

本指南为AUA/ASTRO临床局限性前列腺癌指南三部分系列中的第二部分,阐述主动监测、手术治疗及初始治疗后随访的原则。指南基于系统综述与共识制定推荐条款,旨在为临床医生管理临床局限性前列腺癌患者提供参考。

要点

  • 本部分涵盖主动监测原则、手术原则及初始治疗后随访。
  • 指南声明基于证据与共识制定。
  • 未来高质量试验证据对进一步改善患者照护至关重要。

核心结论

  • 本指南旨在为治疗临床局限性前列腺癌患者的临床医生提供信息。
  • 未来试验持续研究并发表高质量证据,对进一步改善这些男性的照护至关重要。

研究设计与样本

  • 本指南由AUA/ASTRO临床局限性前列腺癌专家组制定,采用基于证据与共识的指南声明。
  • 系统综述由独立方法学顾问实施,研究馆员检索Ovid MEDLINE、Cochrane Central Register of Controlled Trials和Cochrane Database of Systematic Reviews。
  • 方法学团队在电子数据库检索基础上补充了既往AUA综述纳入的研究,并审阅相关文章参考文献列表。

主要发现

  • 专家组制定了关于主动监测、手术管理和患者随访的指南声明。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The summary presented herein represents Part II of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of active surveillance and surgery as well as follow-up for patients after primary treatment. Please refer to Parts I and III for discussion of risk assessment, staging, and risk-based management (Part I), and principles of radiation and future directions (Part III). MATERIALS AND METHODS: The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. A research librarian conducted searches in Ovid MEDLINE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews. The methodology team supplemented searches of electronic databases with the studies included in the prior AUA review and by reviewing reference lists of relevant articles. RESULTS: The Clinically Localized Prostate Cancer Panel created evidence- and consensus-based guideline statements to aid clinicians in the management of patients with clinically localized prostate cancer. Statements regarding active surveillance, surgical management, and patient follow-up are detailed. CONCLUSION: This guideline aims to inform clinicians treating patients with clinically localized prostate cancer. Continued research and publication of high-quality evidence from future trials will be essential to further improve care for these men.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Eastham JA, Auffenberg GB, Barocas DA, et al. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up. J Urol. 2022. PMID: 35536148. doi:10.1097/JU.0000000000002758

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。